アンギナ(狭心症):パイプラインインサイト2018

◆英語タイトル:Angina (Angina Pectoris) - Pipeline Insight, 2018
◆商品コード:DELV201820
◆発行会社(調査会社):DelveInsight
◆発行日:2018年1月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:世界
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Site Price(同一事業所内共有可)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Enterprise Price(複数事業所内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、アンギナ(狭心症)の治療薬開発パイプラインについて調査・分析し、アンギナ(狭心症)の概要、アンギナ(狭心症)の臨床試験段階の治療薬分析、主要な製薬メーカー動向などを含め、以下の構成でお届け致します。
・アンギナ(狭心症)の概要
・アンギナ(狭心症)の治療薬開発パイプライン
・アンギナ(狭心症)の比較分析
・アンギナ(狭心症)の治験段階の製品(医薬品)
・アンギナ(狭心症)の前臨床&創薬段階の製品
・主要企業動向
・治療評価(分析)
【レポートの概要】

“Angina (Angina Pectoris) – Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Angina (Angina Pectoris) development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Angina (Angina Pectoris)
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Angina (Angina Pectoris)
The report assesses the active Angina (Angina Pectoris) pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Angina (Angina Pectoris)
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Angina (Angina Pectoris)
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Angina (Angina Pectoris)
• The report also covers the dormant and discontinued pipeline projects related to the Angina (Angina Pectoris)

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Angina (Angina Pectoris) to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Angina (Angina Pectoris) therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

【レポートの目次】

1. Report Introduction
2. Angina (Angina Pectoris) Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Angina (Angina Pectoris)
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

Table 1: Total Products for Angina (Angina Pectoris)
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products


Figure 1: Total Products for Angina (Angina Pectoris)
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products


【掲載企業】

Ablynx
Amgen Inc.
Asahi Kasei Pharma Corp.
Bayer Healthcare
Boehringer Ingelheim
Cytokinetics Inc.
Eisai Co Ltd.
GenVec
Green Cross Corp.
Juventas Therapeutics Inc.
Korea Otsuka Pharmaceutical Co. Ltd
Kuhnil Pharmaceutical Co. Ltd.
Lectus Therapeutics Ltd
Lee's Pharmaceutical Holdings Ltd.
Milestone Pharmaceuticals Inc.
& list continues...

【レポートのキーワード】

アンギナ(狭心症)

★調査レポート[アンギナ(狭心症):パイプラインインサイト2018] (コード:DELV201820)販売に関する免責事項を必ずご確認ください。
★調査レポート[アンギナ(狭心症):パイプラインインサイト2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆